Word

AOA

Status

Pending

Status Code

653

Status Date

Tuesday, March 5, 2024

Serial Number

98192134

Mark Type

4000

Filing Date

Friday, September 22, 2023

Trademark Owner History

AOA Dx Inc.

Classifications

41 Providing a website featuring blogs and non-downloadable publications in the nature of articles and reports in the fields of biotechnology, medicine, and diagnostic apparatus for the detection of cancer, ovarian cancer, other cellular and tissue-based diseases and disorders, and other diseases

9 Electronic downloadable publications, namely, articles and reports in the fields of biotechnology, medicine, and diagnostic apparatus for the detection of cancer, ovarian cancer, other cellular and tissue-based diseases and disorders, and other diseases

35 Providing consumer product information relating to diagnostic apparatus for the detection of cancer, ovarian cancer, other cellular and tissue-based and diseases and disorders, and other diseases

44 Providing medical information; providing medical information in the field of diagnostic apparatus for the detection of cancer, ovarian cancer, other cellular and tissue-based diseases and disorders, and other diseases; medical consultations; medical consultations in the field of diagnostic apparatus for the detection of cancer, ovarian cancer, other cellular and tissue-based diseases and disorders, and other diseases

10 Diagnostic apparatus for the early detection of cancer, other cellular and tissue-based and diseases and disorders, and other diseases; medical diagnostic apparatus for detecting cancer, other cellular and tissue-based and diseases and disorders, and other diseases; medical diagnostic apparatus for testing for cancer, other cellular and tissue-based and diseases and disorders, and other diseases; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing

42 Scientific research and development; product research and development; research and development in the fields of biotechnology, medicine, and diagnostic apparatus for the detection of cancer, ovarian cancer, other cellular and tissue-based diseases and disorders, and other diseases; consulting services in the field of research and development of biotechnology, medicine, and diagnostic apparatus for the detection of cancer, ovarian cancer, other cellular and tissue-based diseases and disorders, and other diseases; providing information in the field of research and development of biotechnology, medicine, and diagnostic apparatus for the detection of cancer, ovarian cancer, other cellular and tissue-based diseases and disorders, and other diseases; providing medical and scientific research information in the field of biotechnology, medicine, and diagnostic apparatus for the detection of cancer, ovarian cancer, other cellular and tissue-based diseases and disorders, and other diseases; providing temporary use of non-downloadable software for physicians and healthcare providers to input and upload clinical and diagnostic data and to receive information, analyses, and reports in the field of diagnostics related to cancer, ovarian cancer, other cellular and tissue-based diseases and disorders, and other diseases; providing a website featuring technology that allows physicians and healthcare providers to input and upload clinical and diagnostic data and to receive information, analyses, and reports in the field of diagnostics related to cancer, ovarian cancer, other cellular and tissue-based diseases and disorders, and other diseases

Trademark Events

Mar 5, 2024

Notification Of Letter Of Suspension E-Mailed

Mar 5, 2024

Letter Of Suspension E-Mailed

Mar 5, 2024

Suspension Letter Written

Feb 3, 2024

Teas/Email Correspondence Entered

Feb 2, 2024

Correspondence Received In Law Office

Feb 2, 2024

Teas Response To Office Action Received

Nov 16, 2023

Notification Of Non-Final Action E-Mailed

Nov 16, 2023

Non-Final Action E-Mailed

Nov 16, 2023

Non-Final Action Written

Nov 15, 2023

Assigned To Examiner

Oct 10, 2023

New Application Office Supplied Data Entered

Sep 26, 2023

New Application Entered